Prevalence of Macrolide-Resistant Mycoplasma pneumoniae Infections After the COVID-19 Pandemic in Southern Italy, 2023–2025
The post-pandemic resurgence of M. pneumoniae in Southern Italy, coupled with sustained macrolide resistance, underscores the need for continuous molecular surveillance and targeted antimicrobial stewardship to optimize therapy and prevent further resistance spread.
Authors
- Daniele Casulli
- Vittoria Scolamacchia
- Davide Sacco (ORCID: https://orcid.org/0009-0003-4272-3362)
- Marisa Accogli (ORCID: https://orcid.org/0000-0001-8628-1963)
- Francesca Centrone (ORCID: https://orcid.org/0000-0003-3018-5408)
- Anna Sallustio
- Maria Chironna (ORCID: https://orcid.org/0000-0002-1043-1256)
- Alfredo Marziani
- Nicola Netti
- Valentina Annachiara Orlando
- Raffaella Melilli
Institutions
- Azienda Universitaria Ospedaliera Consorziale - Policlinico Bari (IT)
- University of Bari Aldo Moro (IT)
Publication Details
- Journal
- Infectious Diseases and Therapy
- Published
- 2025-10-08
- DOI
- https://doi.org/10.1007/s40121-025-01244-w
- Citations
- 1
- Primary Topic
- Pneumonia and Respiratory Infections
- Type
- article
- Field-Weighted Citation Impact
- 1.35